922 related articles for article (PubMed ID: 15301543)
21. ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes.
Sahoo D; Trischuk TC; Chan T; Drover VA; Ho S; Chimini G; Agellon LB; Agnihotri R; Francis GA; Lehner R
J Lipid Res; 2004 Jun; 45(6):1122-31. PubMed ID: 14993246
[TBL] [Abstract][Full Text] [Related]
22. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
23. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
[TBL] [Abstract][Full Text] [Related]
24. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
Laccotripe M; Makrides SC; Jonas A; Zannis VI
J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
[TBL] [Abstract][Full Text] [Related]
25. Alteration of negatively charged residues in the 89 to 99 domain of apoA-I affects lipid homeostasis and maturation of HDL.
Kateifides AK; Gorshkova IN; Duka A; Chroni A; Kardassis D; Zannis VI
J Lipid Res; 2011 Jul; 52(7):1363-72. PubMed ID: 21504968
[TBL] [Abstract][Full Text] [Related]
26. apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.
Fotakis P; Vezeridis A; Dafnis I; Chroni A; Kardassis D; Zannis VI
J Lipid Res; 2014 Jul; 55(7):1310-23. PubMed ID: 24776540
[TBL] [Abstract][Full Text] [Related]
27. Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiency.
Chroni A; Duka A; Kan HY; Liu T; Zannis VI
Biochemistry; 2005 Nov; 44(43):14353-66. PubMed ID: 16245952
[TBL] [Abstract][Full Text] [Related]
28. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
[TBL] [Abstract][Full Text] [Related]
29. The N-terminal globular domain and the first class A amphipathic helix of apolipoprotein A-I are important for lecithin:cholesterol acyltransferase activation and the maturation of high density lipoprotein in vivo.
Scott BR; McManus DC; Franklin V; McKenzie AG; Neville T; Sparks DL; Marcel YL
J Biol Chem; 2001 Dec; 276(52):48716-24. PubMed ID: 11602583
[TBL] [Abstract][Full Text] [Related]
30. An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration.
Chen X; Burton C; Song X; McNamara L; Langella A; Cianetti S; Chang CH; Wang J
Int J Biol Sci; 2009 Jul; 5(5):489-99. PubMed ID: 19680471
[TBL] [Abstract][Full Text] [Related]
31. Lipidation of apolipoprotein A-I by ATP-binding cassette transporter (ABC) A1 generates an interaction partner for ABCG1 but not for scavenger receptor BI.
Lorenzi I; von Eckardstein A; Radosavljevic S; Rohrer L
Biochim Biophys Acta; 2008; 1781(6-7):306-13. PubMed ID: 18485926
[TBL] [Abstract][Full Text] [Related]
32. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
[TBL] [Abstract][Full Text] [Related]
33. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I.
Rye KA; Barter PJ
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):421-8. PubMed ID: 14592845
[TBL] [Abstract][Full Text] [Related]
34. Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase.
Durbin DM; Jonas A
J Lipid Res; 1999 Dec; 40(12):2293-302. PubMed ID: 10588955
[TBL] [Abstract][Full Text] [Related]
35. Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein.
Huang W; Matsunaga A; Li W; Han H; Hoang A; Kugi M; Koga T; Sviridov D; Fidge N; Sasaki J
Atherosclerosis; 2001 Nov; 159(1):85-91. PubMed ID: 11689210
[TBL] [Abstract][Full Text] [Related]
36. The effect of apolipoprotein A-II on the structure and function of apolipoprotein A-I in a homogeneous reconstituted high density lipoprotein particle.
Durbin DM; Jonas A
J Biol Chem; 1997 Dec; 272(50):31333-9. PubMed ID: 9395462
[TBL] [Abstract][Full Text] [Related]
37. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles.
Liu L; Bortnick AE; Nickel M; Dhanasekaran P; Subbaiah PV; Lund-Katz S; Rothblat GH; Phillips MC
J Biol Chem; 2003 Oct; 278(44):42976-84. PubMed ID: 12928428
[TBL] [Abstract][Full Text] [Related]
38. The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1.
Panagotopulos SE; Witting SR; Horace EM; Hui DY; Maiorano JN; Davidson WS
J Biol Chem; 2002 Oct; 277(42):39477-84. PubMed ID: 12181325
[TBL] [Abstract][Full Text] [Related]
39. Adipocyte modulation of high-density lipoprotein cholesterol.
Zhang Y; McGillicuddy FC; Hinkle CC; O'Neill S; Glick JM; Rothblat GH; Reilly MP
Circulation; 2010 Mar; 121(11):1347-55. PubMed ID: 20212278
[TBL] [Abstract][Full Text] [Related]
40. High density lipoprotein structure-function and role in reverse cholesterol transport.
Lund-Katz S; Phillips MC
Subcell Biochem; 2010; 51():183-227. PubMed ID: 20213545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
